Net-Present Value Still a Top Priority for Pharmaceutical In-Licensing Deals RESEARCH TRIANGLE PARK, NC--(Marketwire - Jun 21, 2011) - When evaluating a deal's potential profitability, pharmaceutical business development and licensing teams use similar criteria regardless of...